San Francisco, California, United States United States
  • Overview
  • Team
  • Activities
Company description

Enso has developed an Apple-like wearable device which delivers treatment that has recently been proven in clinical trials to be 2x as effective as Vicodin. The device is included as part of a coaching program that helps chronic pain patients manage their pain without drugs. The company is backed by physicians at Stanford and UCSF and investors including Cedars-Sinai Medical Center, Felicis Ventures and other top Silicon Valley VC firms.

Business model

We sell devices directly to patients and through insurance via healthcare provider channels. 

Competitive advantage

We have a patented solution which is 10x better than existing chronic pain treatments. Our IP allows us to create additional therapy, diagnostic and remote monitoring solutions that we have an exclusive ability to sell and market worldwide. The design of our products and services also enable new business models for selling through pain clinics in ways that are not possible with existing treatments.